← SynDRA
BRANAPLAM
SynDRA canonical compound SYN0039362 — structure-anchored drug synonym record
| Clinical phase | Phase 1/Phase 2 |
| Primary target(s) | SMN1 |
| Mechanism of action | survival motor neuron protein modulator |
All known targets
Mechanisms of action (all sources)
- survival motor neuron protein modulator
- Modulator
Cross-references
Synonyms
- Nvs-sm1
- LMI-070
- LMI070
- NVP-LMI070-NX
- NVS-SM1
- UNII-P12R69543A
- P12R69543A
- 5-(1H-pyrazol-4-yl)-2-(6-((2,2,6,6-tetramethylpiperidin-4-yl)oxy)pyridazin-3-yl)phenol
- Branaplam [INN]
- SCHEMBL15475826
- LMI070 (NVS-SM1)
- STWTUEAWRAIWJG-UHFFFAOYSA-N
- BCP19909
- ZINC146605125
- AKOS030526592
- CS-5319
- HY-19620
- Phenol, 5-(1H-pyrazol-4-yl)-2-(6-((2,2,6,6-tetramethyl-4-piperidinyl)oxy)-3-pyridazinyl)-
- LMI 070
- Branaplam [USAN]
- BRANAPLAM [WHO-DD]
- branaplamum
- RefChem:570188
- DTXCID301767482
- Branaplam (LMI070)
- MFCD29472288
- Branaplam (USAN/INN)
- Branaplam [USAN:INN]
- LMI070;NVS-SM1
- orb1302690
- SCHEMBL22995506
- SCHEMBL29365963
- SCHEMBL29453333
- SCHEMBL29471376
- LMI070 (NVS-SM1)?
- EX-A5962
- BDBM50465914
- s6642
Look up BRANAPLAM in the interactive SynDRA portal →